EPCAM and breast carcinoma: Expression of EpCAM has previously been linked to poorer survival time in several tumour types including breast cancer (Gastl et al, 2000), gallbladder tumours (Prince et al, 2008), and those of the Papilla Vateri (Scheunemann et al, 2007; Prince et al, 2008).